spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Myogen 

 HSMN NewsFeed - 24 Jul 2014
Bioheart Announces World's First Combination Stem Cell Treatment
Regenerative Medicine Cardiology
 HSMN NewsFeed - 12 Feb 2014
Dan Mitchell Joins ARCA biopharma Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 22 Jul 2013
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2010
MicroPhage, Inc. appoints Alene A. Campbell as CEO
Diagnostics Personnel
 HSMN NewsFeed - 22 Feb 2010
QLT Names Joseph L. Turner to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2009
Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jul 2009
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2009
BAROFOLD, INC. APPOINTS J. WILLIAM FREYTAG, Ph.D. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2009
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
Regenerative Medicine Cardiology Reimbursement
 HSMN NewsFeed - 12 Jan 2009
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 1 Dec 2008
Bioheart Files for Reimbursement Approval in Europe for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
Regenerative Medicine Cardiology Reimbursement
 HSMN NewsFeed - 30 Sep 2008
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Devices Venture Capital
 HSMN NewsFeed - 12 Aug 2008
Follica Announces $11M in New Financing and Expanded Team
Devices Personnel Venture Capital
 HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Devices Dermatology Venture Capital
 HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jul 2007
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2007
Cylene Pharmaceuticals Appoints David M. Ryckman, Ph.D. as Vice President of Manufacturing and Pharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 30 Apr 2007
ReVision Optics, Inc. Raises $25M in Series D Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 18 Dec 2006
Gilead Submits New Drug Application To U.S. FDA for Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2006
Bioheart, Inc. Expands Clinical Trials of Adult Myogenic Stem Cell Treatment for Heart Attack and Advanced Heart Failure Patients
Regenerative Medicine Cardiology
 HSMN NewsFeed - 6 Nov 2006
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2006
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2006
Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2006
Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2006
Ambrisentan Phase 3 ARIES-2 PAH Data Presented At ATS 2006 -- San Diego
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
Myogen
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.